Jan Hendrik Rüschoff
Jan Hendrik Rüschoff
University Hospital Zurich
Verified email at
Cited by
Cited by
Automated Gleason grading of prostate cancer tissue microarrays via deep learning
E Arvaniti, KS Fricker, M Moret, N Rupp, T Hermanns, C Fankhauser, ...
Scientific reports 8 (1), 12054, 2018
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ...
European urology 64 (1), 150-158, 2013
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)
C Rothermundt, S Hayoz, AJ Templeton, R Winterhalder, RT Strebel, ...
European urology 66 (3), 468-474, 2014
Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in …
UJ Muehlematter, IA Burger, AS Becker, K Schawkat, AM Hötker, ...
Radiology 293 (2), 350-358, 2019
A high-performance system for robust stain normalization of whole-slide images in histopathology
A Anghel, M Stanisavljevic, S Andani, N Papandreou, JH Rüschoff, P Wild, ...
Frontiers in medicine 6, 193, 2019
Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis
I Guccini, A Revandkar, M D'Ambrosio, M Colucci, E Pasquini, S Mosole, ...
Cancer cell 39 (1), 68-82. e9, 2021
Expression and mutation patterns of PBRM1, BAP1 and SETD2 mirror specific evolutionary subtypes in clear cell renal cell carcinoma
S Bihr, R Ohashi, AL Moore, JH Rüschoff, C Beisel, T Hermanns, ...
Neoplasia 21 (2), 247-256, 2019
Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11-PET
DA Ferraro, JH Rüschoff, UJ Muehlematter, B Kranzbühler, J Müller, ...
Theranostics 10 (14), 6082, 2020
What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression …
JH Rüschoff, DA Ferraro, UJ Muehlematter, R Laudicella, T Hermanns, ...
European Journal of Nuclear Medicine and Molecular Imaging 48, 4042-4053, 2021
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
DA Ferraro, AS Becker, B Kranzbühler, I Mebert, A Baltensperger, ...
European journal of nuclear medicine and molecular imaging, 1-10, 2021
Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers
T Guo, L Li, Q Zhong, NJ Rupp, K Charmpi, CE Wong, U Wagner, ...
Life science alliance 1 (2), 2018
Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
CD Fankhauser, PJ Schüffler, S Gillessen, A Omlin, NJ Rupp, ...
Oncotarget 9 (12), 10284, 2018
Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
C Poyet, L Buser, F Roudnicky, M Detmar, T Hermanns, D Mannhard, ...
Journal of Clinical Pathology 68 (10), 819-824, 2015
STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment
JH Rüschoff, E Gradhand, A Kahraman, H Rees, JL Ferguson, ...
JCO precision oncology 3, 2019
68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer
DA Ferraro, UJ Muehlematter, HI Garcia Schüler, NJ Rupp, M Huellner, ...
European journal of nuclear medicine and molecular imaging 47, 147-159, 2020
Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins
W Shao, T Guo, NC Toussaint, P Xue, U Wagner, L Li, K Charmpi, Y Zhu, ...
Nature communications 10 (1), 2524, 2019
KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation
K Ikenberg, N Valtcheva, S Brandt, Q Zhong, CE Wong, A Noske, ...
The Journal of pathology 234 (2), 239-252, 2014
KRAS, BRAF, and TP53 deep sequencing for colorectal carcinoma patient diagnostics
M Rechsteiner, A von Teichman, JH Rüschoff, N Fankhauser, ...
The Journal of Molecular Diagnostics 15 (3), 299-311, 2013
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
Q Zhong, JH Rüschoff, T Guo, M Gabrani, PJ Schüffler, M Rechsteiner, ...
Scientific reports 6 (1), 24146, 2016
Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in …
M Rössle, M Sigg, JH Rüschoff, PJ Wild, H Moch, A Weber, ...
Virchows Archiv 463, 623-631, 2013
The system can't perform the operation now. Try again later.
Articles 1–20